Filing Details

Accession Number:
0001455244-10-000118
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-21 13:00:00
Reporting Period:
2010-07-19
Filing Date:
2010-07-21
Accepted Time:
2010-07-21 18:03:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
72444 Nabi Biopharmaceuticals NABI Biological Products, (No Disgnostic Substances) (2836) 591212264
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1459477 W. Matthew Kalnik 8610 Fernwood Road
Bethesda MD 20817
Svp Strategic Plan. & Bus. Ops No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-07-19 1,625 $5.48 45,725 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.